Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences, member-exclusives and 10% off BioTechniques article processing fees

Developing targeted therapeutics: what you need to know

depression and anxiety synapse

Targeted therapeutics development can be a challenging but necessary aspect of your research. To help alleviate its complexity, LI-COR Biosciences (NE, USA) have compiled several processes to help you reach your scientific goals quickly, accurately, and efficiently. Minimize your use of valuable resources and spend more time pursuing your work. 

In this webinar, learn about the different ways that therapeutic assays are being used in current research initiatives around the world. Gain a better understanding of how preclinical research and clinical trials can guide you through the process of targeted therapeutics development. See how you can maximize your own research with LI-COR, whose innovative technology and team of experts can help your research advance with every step.

About the Speaker

Gretchen Hubbard is a Senior Solutions and Support Scientist and Cell-Based Assays Leader at LI-COR Biosciences. She finished her doctoral degree at the University of Maryland Baltimore County where she studied the combinatorial effects of oncogenic expression and tumor suppressor loss in mouse prostate cancer models. She then completed a postdoctoral fellowship at Johns Hopkins University School Medicine in genitourinary pathology, where she identified novel genomic changes associated with prostate cancer progression and examined the role inflammation plays in prostate cancer initiation.

Register now

This content has been provided by LI-COR Biosciences